The Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries is not likely to reach agreements with the COVID vaccine manufacturer that could include the vaccines, although discussions are still ongoing, Reuters told chief executive Kare Schultz.
Schultz said Teva - the world’s largest generic drugmaker – offered to co-produce the vaccines in both Israel and Europe, where the company has capacity to help with global supply.
But we've not been able to reach a firm agreement with any company, he said. It is not for our lack of want to do it, but the key players who have actually been successful in developing the vaccines that have come to the market have found other partners or their own internal capacity.
He has not named the companies.
It's probably pretty much too late we can't rule out, Schultz said. We're still in discussions with some companies, and we're still willing to help if we can.